Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sage Therapeutics Inc.
Sponsor

Sage Therapeutics Inc.

United States 55 Cambridge Pkwy, 02142-1234, United States

About the sponsor

Clinical research activity includes disorders marked by reduced GABAergic neurotransmission and altered cerebellar circuitry, with a strong focus on neuropsychiatric and neurological targets linked to brain network regulation.

  • GABA-related neurobiology
  • Cerebellar function
  • Central nervous system pharmacology

The sponsor’s portfolio reflects interest in compounds designed to modulate inhibitory neurotransmission and measurable cns pharmacodynamic effects in healthy participants.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Study to evaluate the effects of brexanolone and lorazepam on the nervous system in healthy male participants using magnetic brain stimulation

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Lorazepam
  • Sponsor:Sage Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.